Palliative radiotherapy cost acceptable in late-stage lung cancer
A longer, less intense course of radiotherapy provides better value for the money than a shorter, more intense regimen when given to ease pain and other complaints in patients with late-stage non–small-cell lung cancer (NSCLC), according to a study in the December 20 issue of the Journal of the National Cancer Institute.
This entry was posted on Saturday, December 30th, 2006 at 5:37 pm and is filed under Research, Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.